[ET Net News Agency, 25 August 2025] REMEGEN (09995) rose 10.5% to HK$89.6.
It hits an intra-day high of HK$89.6, hitting a 52-week high, and an intra-day low of
HK$80.45. The total shares traded was 7.01 million, with a value of HK$588.73m. The active
buy/sell ratio is 60:40, with net buying turnover of HK$112.1m. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$5.89m, with volume weighted
average price of HK$82.806. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$14.23m, with volume weighted average price of HK$84.057.

Basic Information
=================

----------------------------------
Nominal 89.600 % Chg +10.48%
High 89.600 Low 80.450
Shares Tr 7.01m Turnover 588.73m
10-D SMA 78.125 %H.V 76.715
20-D SMA 70.600 VWAP 83.933
50-D SMA 65.640 RSI14 73.698
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 60:40, with net buying turnover
of HK$112.1m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 89.60 +10.48
SINO BIOPHARM (01177) 8.36 +2.33
3SBIO (01530) 29.98 -3.54
EVEREST MED (01952) 70.10 +0.65
KEYMED BIO-B (02162) 71.20 -2.60
WUXI XDC (02268) 57.60 -0.17
ASCENTAGE-B (06855) 86.85 -4.19
ZAI LAB (09688) 27.18 +1.42
AKESO (09926) 169.70 -4.07
INNOCARE (09969) 18.06 -5.00
---------------------------------------------
(ed)